Suppr超能文献

使用微针接种海藻糖稳定化病毒样颗粒疫苗进行流感免疫接种。

Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles.

作者信息

Kim Yeu-Chun, Quan Fu-Shi, Song Jae-Min, Vunnava Aswani, Yoo Dae-Goon, Park Kyoung-Mi, Compans Richard W, Kang Sang-Moo, Prausnitz Mark R

机构信息

School of Chemical and Biomolecular Engineering, Georgia Institute of Technology.

出版信息

Procedia Vaccinol. 2010;2(1):15-19. doi: 10.1016/j.provac.2010.03.004.

Abstract

Morbidity and mortality due to seasonal and pandemic influenza could be reduced by simpler vaccination methods that enable improved vaccination coverage. In this study, solid metal microneedles coated with influenza virus-like particle (VLP) vaccine were inserted into skin for intradermal immunization. Microneedles were applied to the skin by hand and designed for simple administration with little or no training. Inclusion of trehalose in the coating formulation significantly increased vaccine stability during coating by maintaining hemagglutination activity. Mice vaccinated with stabilized microneedles developed strong antibody responses comparable to conventional intramuscular vaccination and were fully protected against subsequent viral challenge. Whereas, coating microneedles with a coating solution lacking trehalose led to only partial protection against lethal viral challenge. Therefore, our results show that microneedles coated with trehalose-stabilized VLP vaccine can be a promising tool for improving influenza vaccination.

摘要

通过能够提高疫苗接种覆盖率的更简单接种方法,可以降低季节性流感和大流行性流感导致的发病率和死亡率。在本研究中,将涂有流感病毒样颗粒(VLP)疫苗的固体金属微针插入皮肤进行皮内免疫。微针通过手动施加于皮肤,其设计目的是便于简单给药,几乎无需培训。在包衣配方中加入海藻糖,通过维持血凝活性,显著提高了包衣过程中疫苗的稳定性。用稳定化微针接种的小鼠产生了与传统肌肉注射相当的强烈抗体反应,并对随后的病毒攻击具有完全的保护作用。然而,用缺乏海藻糖的包衣溶液包被微针只能对致死性病毒攻击提供部分保护。因此,我们的结果表明,涂有海藻糖稳定化VLP疫苗的微针可能是改善流感疫苗接种的一种有前景的工具。

相似文献

1
Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles.
Procedia Vaccinol. 2010;2(1):15-19. doi: 10.1016/j.provac.2010.03.004.
2
Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.
J Control Release. 2010 Mar 3;142(2):187-95. doi: 10.1016/j.jconrel.2009.10.013. Epub 2009 Oct 17.
3
Formulation of microneedles coated with influenza virus-like particle vaccine.
AAPS PharmSciTech. 2010 Sep;11(3):1193-201. doi: 10.1208/s12249-010-9471-3. Epub 2010 Jul 30.
5
Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.
PLoS One. 2009 Sep 25;4(9):e7152. doi: 10.1371/journal.pone.0007152.
6
Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.
J Control Release. 2013 Dec 10;172(2):579-88. doi: 10.1016/j.jconrel.2013.04.016. Epub 2013 Apr 30.
7
Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.
Clin Vaccine Immunol. 2013 Sep;20(9):1433-9. doi: 10.1128/CVI.00251-13. Epub 2013 Jul 17.
9
Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.
J Control Release. 2010 Nov 1;147(3):326-32. doi: 10.1016/j.jconrel.2010.07.125. Epub 2010 Aug 6.
10
Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.
Pharm Res. 2011 Jan;28(1):135-44. doi: 10.1007/s11095-010-0134-6. Epub 2010 Apr 13.

引用本文的文献

5
Progress in microneedle array patch (MAP) for vaccine delivery.
Hum Vaccin Immunother. 2021 Jan 2;17(1):316-327. doi: 10.1080/21645515.2020.1767997. Epub 2020 Jul 15.
6
The potential role of using vaccine patches to induce immunity: platform and pathways to innovation and commercialization.
Expert Rev Vaccines. 2020 Feb;19(2):175-194. doi: 10.1080/14760584.2020.1732215. Epub 2020 Mar 17.
7
Microneedle Coating Methods: A Review with a Perspective.
J Pharmacol Exp Ther. 2019 Sep;370(3):555-569. doi: 10.1124/jpet.119.258707. Epub 2019 Jun 7.
8
Trehalose prevents aggregation of exosomes and cryodamage.
Sci Rep. 2016 Nov 8;6:36162. doi: 10.1038/srep36162.
9
Cutaneous immunization: an evolving paradigm in influenza vaccines.
Expert Opin Drug Deliv. 2014 Apr;11(4):615-27. doi: 10.1517/17425247.2014.885947. Epub 2014 Feb 12.
10
Microneedle patches for vaccine delivery.
Clin Exp Vaccine Res. 2014 Jan;3(1):42-9. doi: 10.7774/cevr.2014.3.1.42. Epub 2013 Dec 18.

本文引用的文献

2
Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.
J Control Release. 2010 Mar 3;142(2):187-95. doi: 10.1016/j.jconrel.2009.10.013. Epub 2009 Oct 17.
3
Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.
PLoS One. 2009 Sep 25;4(9):e7152. doi: 10.1371/journal.pone.0007152.
4
Improved influenza vaccination in the skin using vaccine coated microneedles.
Vaccine. 2009 Nov 16;27(49):6932-8. doi: 10.1016/j.vaccine.2009.08.108. Epub 2009 Sep 15.
5
Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans.
J Clin Virol. 2009 Jul;45(3):169-73. doi: 10.1016/j.jcv.2009.06.006. Epub 2009 Jun 11.
6
Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge.
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7968-73. doi: 10.1073/pnas.0812652106. Epub 2009 Apr 27.
7
Seasonal influenza vaccines: evolutions and future trends.
Expert Rev Vaccines. 2009 Apr;8(4):383-9. doi: 10.1586/erv.09.9.
8
Transdermal influenza immunization with vaccine-coated microneedle arrays.
PLoS One. 2009;4(3):e4773. doi: 10.1371/journal.pone.0004773. Epub 2009 Mar 10.
9
The biology of influenza viruses.
Vaccine. 2008 Sep 12;26 Suppl 4(Suppl 4):D49-53. doi: 10.1016/j.vaccine.2008.07.039.
10
Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
Vaccine. 2009 Jan 14;27(3):454-9. doi: 10.1016/j.vaccine.2008.10.077. Epub 2008 Nov 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验